| [1] |
Strahl BD,Allis CD. The language of covalent histone modifications[J]. Nature, 2000, 403(6765): 41-45.
|
| [2] |
Jenuwein T,Allis CD. Translating the histonecode[J]. Science, 2001, 293(5532): 1074-1080.
|
| [3] |
Saha RN,Pahan K. HATs and HDACs in neurodegeneration: a tale of disconcerted acetylation homeostasis[J]. Cell Death Differ, 2006, 13(4): 539-550.
|
| [4] |
Boutillier AL,Trinh E,Loeffler JP. Selective E2F-dependent gene transcription is controlled by histone deacetylase activity during neuronal apoptosis[J]. J Neurochem, 2003, 84(4): 814-828.
|
| [5] |
Burton BS. On the propyl derivatives and decomposition products of ethylacetoacetate[J]. Am Chem J, 1882, 3: 385-395.
|
| [6] |
Meunier H,Carraz G,Meunier Y, et al. Proprietes pharmacodynamiques de l'acide n-dipropylacetique. ler Memoire: Proprietes antiepileptiques[J]. Therapie, 1963, 18: 435-438.
|
| [7] |
Carraz G,Farr R,Chateau R, et al. First clinical trials of the antiepileptic activity of N-dipropylacetic acid[J]. Ann Med Psychol, 1964, 122: 577-584.
|
| [8] |
Lambert PA,Carraz G,Borselli S, et al. Neuropsychotropic action of a new anti-epileptic agent: depamide[J]. Ann Med Psychol (Paris), 1966, 124(5): 707-710.
|
| [9] |
Hering R,Kuritzky A. Sodium valproate in the treatment of cluster headache: an open clinical trial[J]. Cephalalgia, 1989, 9(3): 195-198.
|
| [10] |
Peterson GM,Naunton M. Valproate: a simple chemical with so much to offer[J]. J Clin Pharm Ther, 2005, 30(5): 417-421.
|
| [11] |
Chuang DM,Leng Y,Marinova Z, et al. Multiple roles of HDAC inhibition in neurodegenerative conditions[J]. Trends Neurosci, 2009, 32(11): 591-601.
|
| [12] |
Petzold A,Tisdall MM,Girbes AR, et al. In vivo monitoring of neuronal 1oss in traumatic brain injury: a microdialysis study[J]. Brain, 2011, 34(Pt 2): 464-483.
|
| [13] |
Szmydyger - Chodobska J,Strazielle N,Gandy JR, et al. Posttraumatic invasion of monocytes across the blood-cerebrospinal fluid barrier[J]. J Cereb Blood Flow Metab, 2012, 32(1): 93-104.
|
| [14] |
Maiese K. Taking aim at Alzheimer's disease through the mammalian target of rapamycin[J]. Ann Med, 2014, 46(8): 587-596.
|
| [15] |
Chen S,Wu H,Klebe D, et al. Valproic acid: a new candidate of therapeutic application for the acute central nervous system injuries[J]. Neurochem Res, 2014, 39(9): 1621-1633.
|
| [16] |
Ying GY,Jing CH,Li JR, et al. Neuroprotective effects of valproic acid on blood-brain barrier disruption and apoptosis-related early brain injury in rats subjected to subarachnoid hemorrhage are modulated by heat shock protein 70/matrix metalloproteinases and heat shock protein 70/AKT pathways[J]. Neurosurgery, 2016, 79(2): 286-295.
|
| [17] |
Marinova Z,Leng Y,Leeds P, et al. Histone deacetylase inhibition alters histone methylation associated with heat shock protein 70 promoter modifications in astrocytes and neurons[J]. Neuropharmacology, 2011, 60(7-8): 1109-1115.
|
| [18] |
Wang Z,Zhou L,Zheng X, et al. Autophagy protects against PI3K/Akt/mTOR - mediated apoptosis of spinal cord neurons after mechanical injury[J]. Neurosci Lett, 2017, 656: 158-164.
|
| [19] |
Bambakidis T,Dekker SE,Liu B, et al. Hypothermia and valproic acid activate prosurvival pathways after hemorrhage[J]. J Surg Res, 2015, 196(1): 159-165.
|
| [20] |
Li Z,Wu F,Zhang X, et al. Valproate attenuates endoplasmic reticulum stress - induced apoptosis in SH - SY5Y cells via the AKT/GSK3β signaling pathway[J]. Int J Mol Sci, 2017, 18(2): E315.
|
| [21] |
Jiang HZ,Wang SY,Yin X, et al. Downregulation of homer1b/c in SOD1 G93A models of ALS: a novel mechanism of neuroprotective effect of lithium and valproic acid[J]. Int J Mol Sci, 2016, 17(12): E2129.
|
| [22] |
Dekker SE,Bambakidis T,Sillesen M, et al. Effect of pharmacologic resuscitation on the brain gene expression profiles in a swine model of traumatic brain injury and hemorrhage[J]. J Trauma Acute Care Surg, 2014, 77(6): 906-912.
|
| [23] |
Lenzlinger PM,Morganti - Kossmann MC,Laurer HL, et al. The duality of the inflammatory response to traumatic brain iniury[J]. Mol Neumbiol, 2001, 24(1-3): 169-181.
|
| [24] |
Bambakidis T,Dekker SE,Sillesen M, et al. Resuscitation with valproic acid alters in ammatory genes in a porcine model of combined traumatic brain injury and hemorrhagic shock[J]. J Neurotrauma, 2016, 33(16): 1514-1521.
|
| [25] |
Suda S,Katsura K,Kanamaru T, et al. Valproic acid attenuates ischemia - reperfusion injury in the rat brain through inhibition of oxidative stress and inflammation[J]. Eur J Pharmacol, 2013, 707(1-3): 26-31.
|
| [26] |
Zhang Z,Zhang ZY,Wu Y, et al. Valproic acid ameliorates inflammation in experimental autoimmune encephalomyelitis rats[J]. Neuroscience, 2012, 221: 140-150.
|
| [27] |
Martinon F,Burns K,Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta[J]. Mol Cell, 2002, 10(2): 417-426.
|
| [28] |
Bauernfeind FG,Horvath G,Stutz A, et al. Cutting edge: NF - kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression[J]. J Immunol, 2009, 183(2): 787-791.
|
| [29] |
Fann DY,Lee SY,Manzanero S, et al. Intravenous immunoglobulin suppresses NLRP1 and NLRP3 inflammasome-mediated neuronal death in ischemic stroke[J]. Cell Death Dis, 2013, 4: e790.
|
| [30] |
Liu HD,Li W,Chen ZR, et al. Expression of the NLRP3 inflammasome in cerebral cortex after traumatic brain injury in a rat model[J]. Neurochem Res, 2013, 38(10): 2072-2083.
|
| [31] |
Li R,Aslan A,Yan R, et al. Histone deacetylase inhibition and IκB Kinase/nuclear factor - κB blockade ameliorate microvascular proinflammatory responses associated with hemorrhagic shock/resuscitation in mice[J]. Crit Care Med, 2015, 43(12): e567-580.
|
| [32] |
Suda S,Katsura K,Kanamaru T, et al. Valproic acid attenuates ischemia - reperfusion injury in the rat brain through inhibition of oxidative stress and inflammation[J]. Eur J Pharmacol, 2013, 707(1-3): 26-31.
|
| [33] |
Peng GS,Li G,Tzeng NS, et al. Valproate pretreatment protects dopaminergic neurons from LPS-induced neurotoxicity in rat primary midbrain cultures: role of microglia[J]. Brain Res Mol Brain Res, 2005, 134(1):162-169.
|
| [34] |
Fourcade S,Ruiz M,Guilera C, et al. Valproic acid induces antioxidant effects in X-linked adrenoleukodystrophy[J]. Hum Mol Genet, 2010, 19(10): 2005-2014.
|
| [35] |
Xue M,Fan Y,Liu S, et al. Contributions of multiple proteases to neurotoxicity in a mouse model of intracerebral haemorrhage[J]. Brain, 2009, 132(1): 26-36.
|
| [36] |
Wang Z,Leng Y,Tsai LK, et al. Valproic acid attenuates blood-brain barrier disruption in a rat model of transient focal cerebral ischemia: the roles of HDAC and MMP-9 inhibition[J]. J Cereb Blood Flow Metab, 2011, 31(1): 52-57.
|
| [37] |
Lee JY,Kim HS,Choi HY, et al. Valproic acid attenuates blood-spinal cord barrier disruption by inhibiting matrix metalloprotease-9 activity and improves functional recovery after spinal cord injury[J]. J Neurochem, 2012, 121(5): 818-829.
|
| [38] |
Allen SJ,Watson JJ,Shoemark DK, et al. GDNF, NGF and BDNF as therapeutic options for neurodegeneration[J]. Pharmacol Ther, 2013, 138(2): 155-175.
|
| [39] |
Hasan MR,Kim JH,Kim YJ, et al. Effect of HDAC inhibitors on neuroprotection and neurite outgrowth in primary rat cortical neurons following ischemic insult[J]. Neurochem Res, 2013, 38(9): 1921-1934.
|
| [40] |
Kimura A,Namekata K,Guo X, et al. Neuroprotection, growth factors and BDNF-TrkB signalling in retinal degeneration[J]. Int J Mol Sci, 2016, 17(9): E1584.
|
| [41] |
Varela RB,Valvassori SS,Lopes-Borges J, et al. Sodium butyrate and mood stabilizers block ouabain-induced hyperlocomotion and increase BDNF, NGF and GDNF levels in brain of Wistar rats[J]. J Psychiatr Res, 2015, 61: 114-121.
|
| [42] |
Wu X,Chen PS,Dallas S, et al. Histone deacetylase inhibitors up-regulate astrocyte GDNF and BDNF gene transcription and protect dopaminergic neurons[J]. Int J Neuropsychopharmacol, 2008, 11(8): 1123-1134.
|
| [43] |
Bredy TW,Wu H,Crego C, et al. Histone modifications around individual BDNF gene promoters in prefrontal cortex are associated with extinction of conditioned fear[J]. Learn Mem, 2007, 14(4): 268-276.
|
| [44] |
Lee JT,Chou CH,Cho NY, et al. Post-insult valproate treatment potentially improved functional recovery in patients with acute middle cerebral artery infarction[J]. Am J Transl Res, 2014, 6(6): 820-830.
|
| [45] |
Harrison IF,Crum WR,Vernon AC, et al. Neurorestoration induced by the HDAC inhibitor sodium valproate in the lactacystin model of Parkinson's is associated with histone acetylation and up-regulation of neurotrophic factors[J]. Br J Pharmacol, 2015, 172(16): 4200-4215.
|
| [46] |
Azuchi Y,Kimura A,Guo X, et al. Valproic acid and ASK1 deficiency ameliorate optic neuritis and neurodegeneration in an animal model of multiple sclerosis[J]. Neurosci Lett, 2017, 639: 82-87.
|